Cynthia Watchmaker, the School of Pharmacy’s associate dean of student affairs, was awarded the UCSF Chancellor’s Award for Exceptional University Management.
Research on topics ranging from drug abuse to heart pump complications took top honors at the Department of Clinical Pharmacy’s 21st annual Spring Research Seminar.
New and established AIMBE fellows (left to right): Shuvo Roy, PhD, Julius Guccione, PhD, Thomas Link, PhD, Tanja Kortemme, PhD, Atul Butte, PhD, and Tejal Desai, PhD.
School of Pharmacy faculty members Tanja Kortemme and Tejal Desai both received honors at the annual meeting of the American Institute for Medical and Biological Engineering.
Mary Anne Koda-Kimble, PharmD, former dean of the School of Pharmacy
The 2019 Mary Anne Koda-Kimble Seed Award for Innovation will fund nine bold research projects, ranging from studies of the molecular underpinnings of cancer to focus groups designed to prepare PharmD students for experiential learning.
A team led by Pamela England, PhD, identified a new target (yellow) for future Parkinson’s disease therapies within the Nurr1 protein (blue).
Scientists in the UCSF School of Pharmacy recently identified the first drug-binding target site on a molecule known to play a role in Parkinson's disease, opening the door to a new generation of therapies for the condition.
Michael Keiser, PhD, received a Ben Barres Early Career Acceleration Award from the Chan Zuckerberg Initiative, which will support his research into novel therapies for neurodegeneration.
Michael Keiser, PhD, received a Ben Barres Early Career Acceleration Award from the Chan Zuckerberg Initiative, which will fund his research into novel therapies for neurodegeneration.
Paul Ortiz de Montellano, PhD, is an expert on P450 enzymes and his latest work looks at their role in tuberculosis infections.
Ortiz de Montellano gained renown for his work with cytochrome P450 enzymes, which help the liver metabolize drugs and other chemicals, and regulate hormone levels.
